Uterine Wall Thickening

Uterine Wall Thickening (Endometrial Hyperplasia)

Uterine wall thickening refers to the excessive thickening of the endometrium — the tissue lining the inside of the uterus that sheds each month during menstrual bleeding — beyond its normal thickness. Medically, this condition is called Endometrial Hyperplasia. This thickening usually results from hormonal imbalances in the body, particularly situations in which estrogen is not adequately balanced by progesterone (known as unopposed estrogen effect). Uterine wall thickening is one of the most common causes of abnormal vaginal bleeding in women (such as heavy, irregular, prolonged, or postmenopausal bleeding). Although most cases of endometrial hyperplasia are benign, some types — particularly those “with atypia” — are considered a precursor lesion for uterine cancer (endometrial cancer). For this reason, when uterine wall thickening is detected or symptoms suggesting it appear, accurately diagnosing the cause, determining its type, and planning appropriate treatment are of great importance, both for relieving current complaints and for managing the possible cancer risk. At her clinic in Ankara, Prof. Dr. Nuray Bozkurt carefully manages the diagnosis, treatment, and follow-up processes of patients suspected of having uterine wall thickening.

What Is Uterine Wall Thickening (Endometrial Hyperplasia)? What Is the Mechanism?

The endometrium, that is, the inner lining of the uterus, changes throughout the menstrual cycle in response to hormonal influences. In the first half of the cycle, it thickens under the effect of estrogen and prepares for pregnancy. Progesterone, secreted after ovulation, then halts this thickening and matures the endometrium. If pregnancy does not occur, progesterone levels drop and the endometrium is shed as menstrual bleeding.

Endometrial hyperplasia occurs when this hormonal balance is disrupted. When there is continuous or high-level estrogen effect that is not adequately balanced by progesterone in the body, the endometrium is continuously stimulated and thickens excessively. This thickening may simply take the form of an increase in tissue quantity (simple hyperplasia), or it may, over time, progress into a riskier form accompanied by abnormalities in cell structure (atypia).

What Are the Causes and Risk Factors of Endometrial Hyperplasia? Why Is It Important?

The main cause of endometrial hyperplasia is prolonged exposure of the body to estrogen without progesterone, that is, unopposed estrogen exposure. Risk factors that can lead to this condition include:

  • Perimenopause and Menopause: During these periods, when ovulation becomes irregular or stops entirely, progesterone production decreases while estrogen production may continue for some time. This hormonal imbalance is the most common risk factor for hyperplasia.
  • Obesity: Fat tissue in the body, especially after menopause, converts androgens into estrogen, increasing estrogen levels in the body. Obesity is an important risk factor for endometrial hyperplasia and cancer.
  • Polycystic Ovary Syndrome (PCOS): Due to chronic ovulation disorder (anovulation), the body experiences continuous estrogen effect, and progesterone is not produced adequately.
  • Estrogen-Secreting Ovarian Tumors: Although rare, some ovarian tumors (e.g., granulosa cell tumor) can secrete excessive amounts of estrogen.
  • Taking Estrogen-Only Hormone Therapy: Especially in postmenopausal women who have not had a hysterectomy, using estrogen-only hormone replacement therapy (HRT) without added progesterone significantly increases the risk of endometrial hyperplasia and cancer. (This type of treatment is not recommended today).
  • Tamoxifen Use: Tamoxifen, used in breast cancer treatment, has an anti-estrogenic effect on breast tissue but exerts a weak estrogenic effect on the endometrium, which can increase the risk of hyperplasia and polyps.
  • Other Factors: Never having given birth (nulliparity), early onset of menstruation (early menarche), late onset of menopause, diabetes, hypertension, a family history of uterine, ovarian, breast, or colon cancer (particularly hereditary conditions such as Lynch syndrome).

Why Is It Important? Endometrial hyperplasia is important because, in addition to reducing quality of life by causing abnormal bleeding and anemia, its types with atypia in particular carry a risk of progressing to uterine cancer (endometrial cancer) if left untreated. With early diagnosis and appropriate treatment, this risk can be managed.

What Are the Symptoms of Uterine Wall Thickening? Which Signs Are Warning Signals?

The most common and most important symptom of endometrial hyperplasia is abnormal vaginal bleeding. The bleeding pattern may present as follows:

  • Excessively Heavy or Prolonged Menstrual Bleeding (Menorrhagia / Hypermenorrhea): Needing to use more pads than normal, passing large clots, bleeding lasting longer than 7 days.
  • Irregular Menstrual Cycles: Periods occurring more frequently or less frequently than expected.
  • Intermenstrual Bleeding or Spotting (Metrorrhagia): Bleeding occurring between two menstrual periods.
  • Postmenopausal Bleeding: Any amount of vaginal bleeding or spotting after entering menopause (after at least 1 year without a period). This should be considered serious until proven otherwise and must always be investigated.

More rarely, symptoms such as pelvic pain or discharge may also accompany the condition. However, sometimes, particularly during the premenopausal period, it may cause no symptoms at all, and uterine wall thickening may be incidentally detected on an ultrasound performed for another reason.

How Is Uterine Wall Thickening Diagnosed? Diagnostic Methods Applied in Ankara

When symptoms or ultrasound findings raise suspicion of uterine wall thickening, the following diagnostic methods are used by Prof. Dr. Nuray Bozkurt in Ankara to establish a definitive diagnosis and determine the type of the condition:

  1. Detailed Medical History and Gynecological Examination: The patient’s bleeding pattern, duration, amount, other symptoms, age, menopausal status, risk factors (obesity, diabetes, medication use, etc.), and family history are carefully reviewed. The gynecological examination is usually normal, but an increase in uterine size or other accompanying pathologies (myoma/fibroid, polyp) may be detected.
  2. Transvaginal Ultrasonography (TVUS): This is the first-line imaging method. It is the most sensitive method for measuring the thickness of the endometrium. The measured thickness is interpreted according to the patient’s age and the stage of the menstrual cycle. In the postmenopausal period, thickness generally above 4-5 mm is considered suspicious and requires further investigation. In the premenopausal period, normal thickness varies according to the day of the menstrual cycle. Ultrasound can also reveal space-occupying lesions such as polyps or myomas within the uterus, or a non-homogeneous appearance of the endometrium. However, ultrasound alone cannot establish a diagnosis of hyperplasia — it only raises suspicion and helps determine the need for biopsy.
  3. Endometrial Biopsy (Taking a Tissue Sample from the Uterus): This is the gold-standard method for the definitive diagnosis of endometrial hyperplasia and determining its type (with or without atypia). The tissue sample obtained is examined in a pathology laboratory. Biopsy can be performed using different methods:
    • Office Biopsy (Pipelle Biopsy): This is the most commonly used method. In an office setting, generally without the need for anesthesia, a thin plastic cannula (pipelle) is inserted through the cervix, and small tissue samples are obtained from the endometrium with the help of suction. The procedure takes a few minutes and may cause a mild cramping sensation.
    • Dilation and Curettage (D&C): After the cervix is dilated with special instruments, the lining of the uterus is scraped with a metal instrument called a curette. It is generally performed under anesthesia. Its use for purely diagnostic purposes has decreased today; it is now preferred more often when office biopsy is insufficient or when heavy bleeding needs to be stopped.
    • Biopsy with Hysteroscopy: A camera is inserted into the uterus to directly visualize the endometrium and take targeted biopsies from suspicious areas. It is one of the most accurate diagnostic methods, especially when there is ultrasound suspicion of a focal lesion such as a polyp or myoma, or when office biopsy has proven insufficient. Polyps or small myomas detected during the same session can be removed.

Types of Endometrial Hyperplasia and Cancer Risk: Why Does It Matter?

The pathology report obtained from the endometrial biopsy determines the type of hyperplasia and the cancer risk. According to the World Health Organization (WHO) 2014 classification, there are two main types:

  1. Hyperplasia Without Atypia (Hyperplasia – Without Atypia): In this type, the endometrium is thickened, but the cells do not show structural abnormalities (atypia) that could be precursors to cancer. This is a benign condition, and the risk of progression to cancer is very low (<5% over the long term). It generally responds well to medical treatment (progestins).
  2. Endometrial Hyperplasia with Atypia (Atypical Hyperplasia / EIN – Endometrial Intraepithelial Neoplasia): In this type, the cells show marked structural abnormalities (atypia) that are considered precursors to cancer. This condition is a precancerous lesion for uterine cancer (endometrial cancer). If left untreated, the risk of progression to cancer is quite high (25-50% or more). Furthermore, in biopsies diagnosed with hyperplasia with atypia, the probability of an already existing cancer being present in the uterus at the same time is also around 30-50%. For this reason, a diagnosis of hyperplasia with atypia is a much more serious condition, and its treatment differs accordingly.

How Is Uterine Wall Thickening (Endometrial Hyperplasia) Treated?

The treatment approach is planned according to the type of hyperplasia determined by the pathology result (with or without atypia), the patient’s age, her desire for future childbearing, other accompanying health issues, and the patient’s preferences. In Ankara, Prof. Dr. Nuray Bozkurt will determine the most suitable treatment option for you:

1. Treatment of Endometrial Hyperplasia Without Atypia:

  • Medical Treatment (Progestin Hormone Therapy): This forms the basis of treatment. The aim is to administer progesterone to balance the excessive stimulatory effect of estrogen on the endometrium and to induce regression of the hyperplastic tissue. Various progestin medications can be used through different routes:
    • Oral Pills: Medications such as medroxyprogesterone acetate or megestrol acetate are used for a specific period (generally at least 6 months).
    • Hormonal Intrauterine Device (IUD): Levonorgestrel-containing intrauterine devices (e.g., Mirena) provide a highly effective treatment by releasing progesterone directly into the uterus, while also offering contraception. This is generally one of the first-choice methods.
    • Other Methods: Monthly or three-monthly progestin injections.
  • Follow-up: During and after medical treatment, regular control endometrial biopsies (generally every 3-6 months) are essential to assess the effectiveness of treatment. Follow-up may also be needed after hyperplasia has regressed to monitor for recurrence risk.
  • Management of Risk Factors: Measures such as losing weight if obese and controlling diabetes can increase treatment success and reduce recurrence risk.
  • Hysterectomy (Removal of the Uterus): Hysterectomy may be an option for patients who do not respond to medical treatment, cannot adhere to treatment, whose bleeding cannot be controlled, or who do not wish to have children — especially those near menopause or already in menopause.

2. Treatment of Endometrial Hyperplasia with Atypia (EIN): Because of its high cancer risk, hyperplasia with atypia requires a more serious approach:

  • Standard Treatment: Hysterectomy (Removal of the Uterus): In women who do not wish to have children or who have completed childbearing, the standard and safest treatment for hyperplasia with atypia is complete removal of the uterus (total hysterectomy). This approach is recommended due to the possibility of an underlying hidden cancer and the high risk of progression to cancer. Removal of the fallopian tubes (salpingectomy) is generally recommended during surgery as well. Whether or not the ovaries are removed (oophorectomy) is decided based on the patient’s age, menopausal status, and other risk factors (removal is generally recommended after menopause). The surgery can be performed laparoscopically (minimally invasive), vaginally, or through open surgery.
  • Fertility-Preserving Treatment (In Very Selected Patients): In young patients who definitely want to have children in the future, who have a high surgical risk, and who fully understand the situation, high-dose progestin therapy (oral or via hormonal IUD) may be tried very carefully with close follow-up. However, the risks of this approach (missing an underlying cancer, progression to cancer despite treatment) must be discussed with the patient in great detail, and the patient must be under very close follow-up (endometrial biopsy and hysteroscopy every 3-6 months). After pregnancy is achieved or childbearing is completed, hysterectomy is generally recommended. This option is not suitable for every patient, and the decision must be made very carefully.

Follow-up Process After Treatment

  • Hyperplasia Without Atypia: After complete response is confirmed with regular biopsies following medical treatment, annual gynecological examination and, if necessary, follow-up with ultrasound/biopsy may be recommended depending on risk factors.
  • Hyperplasia with Atypia: No additional treatment is generally needed after hysterectomy; standard gynecological follow-up is sufficient. Patients who receive fertility-preserving treatment, however, must remain under close follow-up for life, even if treatment is successful.

The Role of Prof. Dr. Nuray Bozkurt in the Treatment of Uterine Wall Thickening

Prof. Dr. Nuray Bozkurt offers comprehensive and reliable care in Ankara to patients presenting with abnormal uterine bleeding and uterine wall thickening (endometrial hyperplasia):

  • Accurate Diagnostic Evaluation: She performs the initial evaluation with a detailed history, examination, and high-resolution transvaginal ultrasonography. When necessary, she performs endometrial biopsy (office biopsy) or biopsy via hysteroscopy, or refers patients to appropriate centers.
  • Expert Interpretation of Pathology Results: She carefully evaluates the pathology report to determine the type of hyperplasia (with or without atypia) and shares the cancer risk with her patient.
  • Personalized Treatment Plan: Together with the patient, she determines the most suitable treatment option (medical treatment — progestins, hormonal IUD; or surgery — hysterectomy) based on the patient’s age, desire for children, type of hyperplasia, and other health conditions.
  • Treatment Administration and Follow-up: She prescribes medical treatment and monitors its effectiveness with regular biopsies. When surgery is needed, she performs hysterectomy (laparoscopically when appropriate) or refers the patient to the relevant surgical units.
  • Comprehensive Information and Support: She informs her patients clearly, understandably, and honestly about their condition, the risks involved, the advantages/disadvantages of treatment options, and the follow-up process. She answers all their questions and provides support throughout the process. Accessibility is essential (0538 983 18 78)(0312 284 00 12).

If you have complaints such as abnormal vaginal bleeding (especially postmenopausal bleeding) or irregular periods, or if uterine wall thickening has been detected on ultrasound, the cause of this condition must definitely be investigated. By consulting Prof. Dr. Nuray Bozkurt at our clinic in Ankara, you can obtain an accurate diagnosis, learn your risk of endometrial hyperplasia, and determine the most appropriate treatment approach for you. Early diagnosis and timely treatment are the most important steps in protecting your health. You can reach us at 0538 983 18 78 to make an appointment.

Frequently Asked Questions

It is the excessive thickening of the endometrium, the layer lining the inside of the uterus, beyond its normal thickness. It is usually caused by hormonal imbalance (unopposed estrogen). Most types are benign (without atypia), but some types (with atypia) carry a risk of progressing to uterine cancer if left untreated. For this reason, it should always be taken seriously and investigated.

The most important symptom is abnormal vaginal bleeding. Very heavy or prolonged periods, irregular periods, intermenstrual bleeding, and especially any bleeding after menopause can be signs of uterine wall thickening and always warrant a visit to the doctor.

No, it is not normal. Any vaginal bleeding or spotting occurring after entering menopause (after at least 1 year without a period) may be a sign of uterine cancer or a precancerous condition until proven otherwise, and must be investigated urgently.

Ultrasound raises suspicion by measuring the thickness of the uterine wall but cannot provide a definitive diagnosis. For a definitive diagnosis and to determine the type of hyperplasia (with or without atypia), a tissue sample must be taken from the uterus (endometrial biopsy) and examined pathologically. Biopsy can be performed in an office setting or via hysteroscopy.

There are two main types: Hyperplasia without atypia (very low cancer risk, generally treated with medication) and Hyperplasia with atypia (a precancerous lesion with a high risk of progressing to cancer, whose standard treatment is generally removal of the uterus). The pathology result determines this distinction.

Yes, the primary treatment for hyperplasia without atypia is medications containing progesterone (pills, hormonal IUD, etc.). These medications generally cause the hyperplasia to regress. The success of treatment is monitored with regular biopsies.

Because hyperplasia with atypia carries a high cancer risk, the standard treatment in women who do not wish to have children is removal of the uterus (hysterectomy). In very young, selected patients who wish to have children, hormone therapy with very close follow-up may be tried, but due to the risks, hysterectomy is generally the first choice.

No. Only endometrial hyperplasia with atypia carries a high risk of progressing to cancer if left untreated. The risk of hyperplasia without atypia progressing to cancer is very low. However, any type of abnormal bleeding and uterine wall thickening must always be investigated.

For hyperplasia with atypia, hysterectomy is generally the standard treatment. For hyperplasia without atypia, medication is tried first; if medical treatment fails or is not suitable for the patient, hysterectomy may be an option. The decision is made based on the patient’s condition and preferences.

If you have complaints of abnormal bleeding or if uterine wall thickening has been detected, you can make an appointment at Prof. Dr. Nuray Bozkurt’s clinic in Ankara by calling 0538 983 18 78 for a detailed evaluation and a treatment plan suited to you.

You can contact us to get information about the diagnosis and treatment process.

Contact

What Is Uterine Wall Thickening (Endometrial Hyperplasia)?

The tissue lining the inner layer of the uterus, which sheds and renews itself with each menstrual cycle, is called the endometrium. Uterine wall thickening, medically known as endometrial hyperplasia, is a condition in which this tissue grows and thickens beyond its normal state. It usually occurs as a result of an imbalance between the hormones estrogen and progesterone. An excessive rise in estrogen that is not balanced by progesterone causes the endometrium to be continuously stimulated and to thicken uncontrollably.

In Ankara, Prof. Dr. Nuray Bozkurt creates a treatment plan for patients presenting with uterine wall thickening by first identifying the hormonal or structural causes underlying the condition. Although this picture is mostly due to benign causes, it should not be taken lightly, since some types carry a risk of progressing to uterine cancer, and it must be carefully monitored by an experienced gynecologist.

Symptoms of Uterine Wall Thickening: Which Situations Pose a Risk?

Uterine wall thickening usually presents itself with pronounced menstrual irregularities. Because the hormonal imbalance in the body prevents the regular shedding of the endometrium, patients typically visit the doctor with the following complaints:

Abnormal Vaginal Bleeding: Menstrual periods lasting much longer than normal or an excessive increase in flow is the most common symptom.
Intermenstrual Bleeding: Spotting or bleeding seen between two menstrual periods may be a sign of irregular growth in the uterine wall.
Short Menstrual Cycles: The interval between two menstrual periods being shorter than 21 days.
Postmenopausal Bleeding: In a woman who has entered menopause, any vaginal bleeding, no matter how small in amount, is of vital importance in terms of the risk of uterine wall thickening or uterine cancer and must be examined without delay.

At our clinic in Ankara, the first step for patients presenting with these symptoms is a detailed ultrasound examination to measure the uterine wall. If the thickness is above normal limits for the patient’s age and day of the menstrual cycle, further investigations are carried out.

Causes and Risk Factors of Uterine Wall Thickening

The main cause of uterine wall thickening is an imbalance between estrogen, the hormone that grows the endometrium, and progesterone, the hormone that limits and controls this growth. If the body does not produce enough progesterone, or if externally taken estrogen is not balanced with progesterone, the uterine wall begins to thicken excessively. The main risk factors leading to this hormonal imbalance are as follows:

Polycystic Ovary Syndrome (PCOS): Because regular ovulation does not occur, progesterone levels remain low, and the uterine wall can thicken as it remains under constant estrogen effect.
Obesity: Fat tissue causes extra estrogen production in the body. Overweight individuals have a higher risk of uterine wall thickening.
Menopausal Transition: During this period, when ovulation becomes irregular, hormone fluctuations set the stage for thickening.
External Hormone Intake: Use of estrogen-only hormone replacement therapies or certain breast cancer medications (such as tamoxifen).
Diabetes and Insulin Resistance: Metabolic problems can indirectly affect hormonal balance and put the endometrium at risk.
Never Having Given Birth: Uninterrupted menstrual cycles continuing for many years and being deprived of the protective effect of pregnancy.

At our center in Ankara, the patient’s lifestyle and hormonal history are examined in detail to determine the root cause of the thickening and to establish the risk level.

Diagnosis of Uterine Wall Thickening: Is Biopsy Necessary?

When uterine wall thickening is suspected, the first step is generally transvaginal ultrasonography. Ultrasound measures the thickness of the endometrium in millimeters. However, ultrasound alone cannot determine whether the thickening is due to a “benign” condition or a “precancerous” cell change. A tissue sample (biopsy) must always be taken for a definitive diagnosis. At our clinic in Ankara, the following methods are used during the diagnostic stage:

Pipelle Biopsy: This is a procedure in which a tissue sample is taken from the uterus in an office setting, without the need for anesthesia, using a thin cannula. It is a very practical and painless method.
Dilation and Curettage (D&C): The cervix is slightly dilated to obtain a more comprehensive sample from the uterus. It is generally performed under light sedation and also has a bleeding-stopping effect.
Hysteroscopy: A lighted camera is inserted into the uterus to directly observe the wall and to take targeted biopsies from suspicious areas. It is the method with the highest diagnostic success rate.

The tissue sample obtained is sent to the pathology laboratory. Based on the result, the type of thickening (with or without atypia) is determined, and the treatment plan is finalized accordingly.

Treatment of Uterine Wall Thickening: What Approach Is Followed?

Treatment of uterine wall thickening is not planned according to a standard protocol for every patient; instead, it is personalized based on the pathology result of the biopsy taken, the patient’s age, the severity of her complaints, and her desire for future childbearing. The main goal of treatment is to restore the endometrium to its previous healthy state and eliminate the cancer risk.

Medication and Hormone Therapies

If the biopsy result reveals thickening “without atypia” (no precancerous change in the cells), the preferred treatment is hormone therapy. Medications containing progesterone are prescribed to balance the effect of estrogen. This treatment can be administered via oral pills, injections, or the more commonly preferred “hormonal intrauterine device” (Mirena). The hormonal IUD releases local progesterone directly into the uterus, thinning the uterine wall while minimizing systemic side effects. Treatment usually lasts 3-6 months, after which a control biopsy is performed to check whether the condition has improved.

Surgical Treatment (Hysterectomy)

In some cases, uterine wall thickening requires surgical intervention. If the biopsy reveals thickening “with atypia” (cell changes carrying a cancer risk), removal of the uterus (hysterectomy) is the safest option, especially for patients who are in menopause or have completed childbearing. Surgery is also brought to the forefront for patients who do not respond to medical treatment, whose thickening recurs after treatment, or whose heavy bleeding cannot be stopped.

Frequently Asked Questions

Is uterine wall thickening cancer?

No, uterine wall thickening is not a cancer. However, the type referred to as “with atypia” in particular carries the potential to progress to uterine cancer (endometrial cancer) over time if left untreated. For this reason, it is vital that the pathology result be correctly interpreted by an experienced physician.

Can thickening recur after treatment?

If the underlying factor causing the thickening (obesity, polycystic ovary syndrome, uncontrolled diabetes, etc.) is not eliminated, there is a risk of recurrence. For this reason, regular gynecological check-ups should not be neglected after treatment, and lifestyle changes should be adhered to.

Does uterine wall thickening prevent pregnancy?

Yes, the endometrium is the site where the embryo must implant. Excessive and irregular thickening of this tissue can make it difficult for the embryo to implant, leading to infertility or, even if pregnancy occurs, an increased risk of early miscarriage. Once treatment restores the wall thickness to normal, the chance of pregnancy increases again.

Does losing weight correct uterine wall thickening?

Obesity is one of the most important factors increasing the amount of estrogen in the body. Although losing weight alone does not treat an advanced-stage thickening, it makes a very significant contribution to establishing hormonal balance and to the success of the medical treatment applied.

Follow-up of Uterine Wall Thickening in Ankara

Uterine wall thickening is a condition that can be easily treated with medication when diagnosed early, but that can lead to risky processes when neglected. Prof. Dr. Nuray Bozkurt carefully manages the entire process, from the biopsy stage through long-term follow-up, at her clinic in Ankara.

If you have complaints of abnormal bleeding or any concerns about the thickness of your uterine wall, it is important that you seek expert support.

Detailed Information and Appointment: 0312 284 00 12